Gaia Mazzocchetti
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.
Journal: Clinical and experimental medicine
Published: February 17, 2025
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma.
Journal: Haematologica
Published: February 16, 2025
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.
Journal: Blood cancer journal
Published: July 01, 2024
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
Journal: Clinical and experimental medicine
Published: May 09, 2023
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
Journal: Nature communications
Published: April 28, 2023
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients.
Journal: International journal of molecular sciences
Published: August 31, 2022
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases.
Journal: Frontiers in oncology
Published: July 22, 2022
BoBafit : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profiles.
Journal: Computational and structural biotechnology journal
Published: April 21, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026